These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15009478)

  • 1. Ethnic background is a determinant of average warfarin dose required to maintain the INR between 3.0 and 4.5.
    Blann A; Bareford D
    J Thromb Haemost; 2004 Mar; 2(3):525-6. PubMed ID: 15009478
    [No Abstract]   [Full Text] [Related]  

  • 2. Audit of correction of high INR in an anticoagulation clinic.
    Hirri HM; Green PJ
    Clin Lab Haematol; 2005 Jun; 27(3):172-6. PubMed ID: 15938722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Validation of R-T Estimation for CoaguChek XS INR Results.
    Richter C; Taylor J; Wright J; Fletcher B
    Ann Pharmacother; 2016 Aug; 50(8):645-8. PubMed ID: 27199494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Comparison of Point-of-Care Device and Standard Analyzer for Monitoring of International Normalized Ratio in Outpatient Oral Anticoagulant Clinic.
    Moiz B; Rashid A; Hasan M; Jafri L; Raheem A
    Clin Appl Thromb Hemost; 2018 Oct; 24(7):1153-1158. PubMed ID: 29374969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin.
    Crowther MA; Ageno W; Schnurr T; Manfredi E; Kinnon K; Garcia D; Douketis JD
    Haematologica; 2005 Jan; 90(1):137-9. PubMed ID: 15642685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher vitamin K intake is associated with better INR control and a decreased need for INR tests in long-term warfarin therapy.
    Leblanc C; Presse N; Lalonde G; Dumas S; Ferland G
    Thromb Res; 2014 Jul; 134(1):210-2. PubMed ID: 24824293
    [No Abstract]   [Full Text] [Related]  

  • 7. Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink.
    Macedo AF; Bell J; McCarron C; Conroy R; Richardson J; Scowcroft A; Sunderland T; Rotheram N
    Thromb Res; 2015 Aug; 136(2):250-60. PubMed ID: 26073321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q; Kim JE; Hyun J; Han KS; Kim HK
    Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial background is a determinant of average warfarin dose required to maintain the INR between 2.0 and 3.0.
    Blann A; Hewitt J; Siddiqui F; Bareford D
    Br J Haematol; 1999 Oct; 107(1):207-9. PubMed ID: 10520043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study.
    Gemmati D; Burini F; Talarico A; Fabbri M; Bertocco C; Vigliano M; Moratelli S; Cuneo A; Serino ML; Avato FM; Tisato V; Gaudio RM
    PLoS One; 2016; 11(9):e0162084. PubMed ID: 27606428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose oral anticoagulation therapy in Chinese children with congenital heart disease.
    Cheung YF; Leung MP
    J Paediatr Child Health; 1998 Dec; 34(6):563-7. PubMed ID: 9928651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Warfarin Management Within the Medical Home: A Health-System Approach.
    Rose AE; Robinson EN; Premo JA; Hauschild LJ; Trapskin PJ; McBride AM
    Am J Med; 2017 Mar; 130(3):365.e7-365.e12. PubMed ID: 27984006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of international normalized ratio values among new warfarin patients with nonvalvular atrial fibrillation.
    Nelson WW; Milentijevic D; Wang L; Baser O; Damaraju CV; Schein JR
    Blood Coagul Fibrinolysis; 2016 Dec; 27(8):899-906. PubMed ID: 26886362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to long-term warfarin therapy remains challenging.
    Ward M
    J Manag Care Pharm; 2013 May; 19(4):290. PubMed ID: 23627574
    [No Abstract]   [Full Text] [Related]  

  • 15. Warfarin therapy: evolving strategies in anticoagulation.
    Horton JD; Bushwick BM
    Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral anticoagulation in the hospital: analysis of patients at risk.
    Dawson NL; Klipa D; O'Brien AK; Crook JE; Cucchi MW; Valentino AK
    J Thromb Thrombolysis; 2011 Jan; 31(1):22-6. PubMed ID: 20396932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral anticoagulation in a pediatric hospital: impact of a quality improvement initiative on warfarin management strategies.
    Moffett BS; Parham AL; Caudilla CD; Mott AR; Gurwitch KD
    Qual Saf Health Care; 2006 Aug; 15(4):240-3. PubMed ID: 16885247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy and clinical usefulness of the CoaguChek S and XS Point of Care devices when starting warfarin in a hospital outreach setting.
    Sobieraj-Teague M; Daniel D; Farrelly B; Coghlan D; Gallus A
    Thromb Res; 2009 Apr; 123(6):909-13. PubMed ID: 19042011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.